Anxiety and depression are often reported among women with BRCA1/2 mutations, most commonly among those who are undergoing genetic testing19, undergoing prophylactic surgeries24, and/or during biannual surveillance appointments30. This evidence concerns the gene BRCA1 and major depressive disorder.